TABLE 5.
| A: Type of Mutation
| |
|---|---|
| Presence of activating mutation | N=34 |
| n (%) | |
| No | 12 (35%) |
| KRAS/BRAF | |
| BRAF | 2 (6%) |
| KRAS | 14 (41%) |
| B: Tumor Response (CR, PR) by BRAF, KRAS, Mutation
| ||||
|---|---|---|---|---|
| Response (CR,PR) | ||||
| N | No n (%) |
Yes n (%) |
p-value† | |
| Total | ||||
| 34 | 27 (79.4%) | 7 (20.6%) | ||
| BRAF Mutation | ||||
| No | 32 | 25 (78.1%) | 7 (21.9%) | 1.000 |
| Yes | 2 | 2 (100.0%) | 0 (0.0%) | |
| KRAS Mutation | ||||
| No | 20 | 15 (75.0%) | 5 (25.0%) | 0.672 |
| Yes | 14 | 12 (85.7%) | 2 (14.3%) | |
| BRAF or KRAS Mutation | ||||
| No | 18 | 13 (72.2%) | 5 (27.8%) | 0.405 |
| Yes | 16 | 14 (87.5%) | 2 (12.5%) | |
†
p-value from Fisher’s Exact test.
Note: Percentages are row percentages.